Lisaftoclax (APG-2575) is a novel BCL-2 inhibitor with robust antitumor activity in preclinical models of hematologic malignancy

被引：0
|
作者：
Paulus, Aneel
Manna, Alak
Wang, Hengbang
Chen, Jianyong
Min, Ping
Yin, Yan
Dutta, Navnita
Halder, Nabanita
Ciccio, Gina
Copland, John
Han, Bing
Bai, Longchuan
Liu, Liu
Wang, Mi
McEachern, Donna
Przybranowski, Sally
Yang, Chao-Yie
Stuckey, Jeanne
Wu, Depei
Li, Caixia
Ryan, Jeremy
Letai, Anthony
Ailawadhi, Sikander
Yang, Dajun
Wang, Shaomeng
Chanan-Khan, Asher
Zhai, Yifan
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549996
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [31] Preclinical characterization of BGB-11417, a potent and selective Bcl-2 inhibitor with superior antitumor activities in haematological tumor models
    Hu, Nan
    Guo, Yunhang
    Xue, Hai
    Liu, Ye
    Guo, Yin
    Wang, Fan
    Song, Xiaomin
    Guo, Ying
    Chen, Shuaishuai
    Xu, Haipeng
    Zhang, Taichang
    Ma, Yanwen
    Sun, Xuebing
    Hong, Yuan
    Zhu, Yutong
    Xu, Aiying
    Cheng, Zhenzhen
    Xing, Haimei
    Wang, Zhiwei
    Liu, Xuesong
    Wang, Lai
    CANCER RESEARCH, 2020, 80 (16)
  • [32] A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models
    Yin, Tinggui
    Lallena, Maria J.
    Kreklau, Emiko L.
    Fales, Kevin R.
    Carballares, Santiago
    Torrres, Raquel
    Wishart, Graham N.
    Ajamie, Rose T.
    Cronier, Damien M.
    Iversen, Phillip W.
    Meier, Timothy I.
    Foreman, Robert T.
    Zeckner, Douglas
    Sissons, Sean E.
    Halstead, Bart W.
    Lin, Aimee B.
    Donoho, Gregory P.
    Qian, Yuewei
    Li, Shuyu
    Wu, Song
    Aggarwal, Amit
    Ye, Xiang S.
    Starling, James J.
    Gaynor, Richard B.
    de Dios, Alfonso
    Du, Jian
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (06) : 1442 - 1456
  • [33] The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
    Fan Luo
    Han Li
    Wenjuan Ma
    Jiaxin Cao
    Qun Chen
    Feiteng Lu
    Miaozhen Qiu
    Penghui Zhou
    Zengfei Xia
    Kangmei Zeng
    Jianhua Zhan
    Ting Zhou
    Qiuyun Luo
    Wentao Pan
    Lin Zhang
    Chaozhuo Lin
    Yan Huang
    Li Zhang
    Dajun Yang
    Hongyun Zhao
    Cellular & Molecular Immunology, 2024, 21 : 60 - 79
  • [34] Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models
    Nguyen, Thinh H.
    Koneru, Balakrishna
    Wei, Sung-Jen
    Chen, Wan Hsi
    Makena, Monish Ram
    Urias, Eduardo
    Kang, Min H.
    Reynolds, C. Patrick
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12) : 2270 - 2282
  • [35] L105, a next generation of Bcl-2 inhibitor, overcomes Bcl-2 mutation and exhibits superior antitumor activity
    Liu, Xingguo
    Lou, Yang
    Wu, Yizhe
    Su, Mingbo
    Gao, Anhui
    Huang, Jinglai
    Zhong, Li
    Zhou, Xinglu
    CANCER RESEARCH, 2023, 83 (07)
  • [36] A novel Bcl-2/Bcl-XL inhibitor APG-1252-12A as a potential therapeutic strategy for gastric carcinoma
    Yan, Xianglei
    Yi, Hanjie
    Luo, Qiuyun
    Yuan, Luping
    Zhou, Suna
    Pan, Wentao
    Zhang, Lin
    Qiu, Miaozhen
    Yang, Dajun
    CANCER RESEARCH, 2019, 79 (13)
  • [37] BCL-2 inhibitor APG-2575 promotes anti-tumor efficacy of immune checkpoint blockade through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer.
    Luo, Fan
    Lu, Fei Teng
    Qiu, Miao Zhen
    Pan, Wen Tao
    Zhang, Lin
    Zhao, Hong Yun
    Zhang, Li
    Yang, Da Jun
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Antitumor activity of Bcl-2 siRNA complexed with cationic liposomes in mouse cancer models
    Hirabayashi, Kazuko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 24P - 24P
  • [39] Discovery of HZ-L105, a Next Generation of Bcl-2 Inhibitor, Overcomes Bcl-2 Mutation and Exhibits Superior Antitumor Activity
    Liu, Xingguo
    Lou, Yang
    Wu, Yizhe
    Su, Mingbo
    Gao, Anhui
    Huang, Jinglai
    Yang, Haiyan
    Zhong, Li
    Zhou, Xinglu
    BLOOD, 2022, 140 : 7798 - 7799
  • [40] Inclusion Complex of a Bcl-2 Inhibitor with Cyclodextrin: Characterization, Cellular Accumulation, and in Vivo Antitumor Activity
    Zhang, Zhichao
    Wu, Guiye
    Gao, Jin
    Song, Ting
    MOLECULAR PHARMACEUTICS, 2010, 7 (04) : 1348 - 1354
12345